Innovations Spotlight

Cleveland Clinic

11/29/2017

Cleveland Clinic's First DBS for Stroke Recovery Patient: 1 Year Later

This year, we’ve been covering Dr. Andre Machado's groundbreaking first deep brain stimulation (DBS) surgery in a patient for the purpose of restoring motor function following ischemic stroke.


Precision Medicine Principles Applied to Prostate Cancer

11/27/2017

Precision Medicine Principles Applied to Prostate Cancer

Cleveland Clinic Glickman Urological & Kidney Institute is leading the precision medicine charge against prostate cancer, and institute members have published a number of milestone studies.


Cleveland Multiport Catheter Enhances Topotecan Delivery in High-Grade Glioma

11/24/2017

Cleveland Multiport Catheter Enhances Topotecan Delivery in High-Grade Glioma

The Cleveland Multiport Catheter (CMC), a novel four-port device for convection-enhanced delivery, successfully conveys high volumes of chemotherapy to enhancing and nonenhancing regions of recurrent high-grade gliomas.


MIS2017 Videos Now Available

11/22/2017

MIS2017 Videos Now Available

Panel videos from MIS2017 are now available!


New Sickle Cell Disease Treatment Shows Positive Results in Phase 1 Clinical Trial

11/20/2017

New Sickle Cell Disease Treatment Shows Positive Results in Phase 1 Clinical Trial

A phase 1 clinical trial has demonstrated safety and preliminary evidence of efficacy for a new combination oral drug to treat sickle cell disease (SCD).


Precision Medicine at Cleveland Clinic

11/16/2017

Precision Medicine at Cleveland Clinic

Hear from Cleveland Clinic Innovation’s 2017 Young Innovator Award Winner, Dr. Mohamed Abazeed, on his innovative efforts to bring precision medicine to cancer care.


MIS2017 Recap: Patients Take Center Stage

11/15/2017

MIS2017 Recap: Patients Take Center Stage

Since its debut in 2002, the Summit has emphasized the story of the company. Listening in on both the business successes and the failures is essential in illuminating the pathway for future companies and technologies.


Cleveland Clinic’s Stanley Hazen, M.D., Ph.D., Recognized as 2017 Distinguished Scientist by The American Heart Association

11/14/2017

Cleveland Clinic’s Stanley Hazen, M.D., Ph.D., Recognized as 2017 Distinguished Scientist by The American Heart Association

Stanley Hazen, M.D., Ph.D., chair of the Department of Cellular & Molecular Medicine in the Lerner Research Institute and section head of Preventive Cardiology & Rehabilitation in the Miller Family Heart & Vascular Institute at Cleveland Clinic, has been named by the American Heart Association (AHA) a Distinguished Scientist for 2017.


Cleveland Clinic Researchers Discover Cancer Stem Cell Pathway in Endometrial Cancer

11/06/2017

Cleveland Clinic Researchers Discover Cancer Stem Cell Pathway in Endometrial Cancer

A team of Cleveland Clinic researchers have discovered a key pathway that leads to recurrence and treatment resistance in endometrial cancer, providing the potential for much needed new therapies for women with limited options.


Thank You for a Fantastic MIS2017

10/26/2017

Thank You for a Fantastic MIS2017

Thank you for joining us in downtown Cleveland and playing a vital role in the future of precision medicine. Thank you to our speakers for their insights, our sponsors for their support, and our attendees for their innovative spirit. 


 <  1 2 3 4 5 6 7 8 9 10  > 

Get In Touch With Us